from controls and PNH patients was separated in five fractions by differential centrifugation. CD59 and DAF on the fractionated erythrocytes were determined by flow cytometry using specific antibodies. Ratios of CD59-and DAF-almost normal positive and partly positive cells to negative erythrocytes were increased progressively from the top fraction to the bottom. The erythrocytes in the top fraction are younger and reticulocyte-rich, while those in the bottom are older and reticulocyte-poor. Hence, the present results indicate that CD59-and DAF-partly positive erythrocytes as well as almost normal positive erythrocytes in patients may have a longer in vivo survival than negative erythrocytes. 0 1992 by The American Society of Hematology.
(1.25 mm inner diameter, 2.0 mm outer diameter, 80 mm length; Teikokuzoki Co, Tokyo, Japan) and centrifuged at 15,OOOg for 15 minutes at room temperature using a Model H-25F1 centrifuge (Kokusan Co, Tokyo, Japan). Then each tube was cut into the five equal parts of the sedimented erythrocyte layer and each part was named fraction 1 to 5 from the top to the bottom. Erythrocytes were collected separately from each fraction. Reticulocytes in each fraction were counted automatically by an auramine-0 method using a Sysmex Model RlOOO counter (Tooa Medical Electronics Co, Kobe, Japan). Most of the reticulocytes were contained in fraction 1 (ie, the younger erythrocyte fraction), with fewer in fractions 2 to 4, and still fewer in fraction 5 (ie, the older erythrocyte fraction), as shown in Fig 1. Erythrocytes were washed with phosphatebuffered saline (PBS) three times. Cells were suspended in PBS at approximately 108/mL. One hundred microliters of suspension was incubated with 10 pL of mouse anti-CD59 monoclonal antibody (MoAb) (from Prof M. Tomita, Showa University, Tokyo, Japan) and mouse anti-DAF monoclonal antibody (Wako Pure Chemical Industries, LTD, Osaka, Japan) at 0°C for 30 minutes. After washing with PBS two times, the suspension was added to 200 pL of diluted goat F(ab')* antimouse Ig's (G + L)-fluorescein isothyocyanate (Tago, Inc, Burlingame, CA) followed by incubation at 0°C for 30 minutes. Then the erythrocytes were washed with PBS two times and prepared for flow cytometry on an Ortho Cytoron (Ortho Diagnostic Systems KK, Tokyo, Japan). The same procedure was performed without anti-CD59 and anti-DAF antibody for a negative control.
Flow cytometry on erythrocytes from normal controls showed a positive fluorescence peak with strong intensity using anti-CD59 and anti-DAF (called CD59-and DAF-normal positive). Cells from patient 2 showed a negative peak (called negative) and a positive peak with almost the same intensity as normal (called almost normal positive). Cells from patients 1 and 3 showed a negative peak and a positive peak with less intensity compared with the intensity of normal erythrocytes (called partly positive). Therefore, CD59-and DAF-positive erythrocytes mean CD.59-and DAF-partly positive cells and almost normal and normal positive cells together. ages of total erythrocytes in Table 1 . CD59-positive erythrocytes were increased progressively in fraction 1 to fraction 5 of the patients. However, all erythrocytes from controls were CD59-positive in each fraction despite cell fractionation. Similar results were obtained for DAF-positive erythrocytes from the patients, though the increment was not so distinct in comparison with CD59. DAF-positive cells from controls were nearly 100% in each fraction.
Flow cytometric profiles of CD59 and DAF on the erythrocytes from patients 1,2, and the control are shown in Fig 2. It is clearly demonstrated that not only CD59-almost normal positive erythrocytes from patient 2, but also CD59-partly positive erythrocytes from patient 1, were increased progressively from fraction 1 to fraction 5. The peak of CD59-negative erythrocytes from the patients was decreased from fraction l to fraction 5. CD59-normal positive erythrocytes from the control were constant in each fraction. Equivalent results to CD59 were obtained for DAF on the erythrocytes from patients 1 and 2, although there were some difficulties to distinguish in patient 2. The peak of DAF normal positive erythrocytes from the control was not changed in each fraction. Peaks of CD59-and DAFnegative erythrocytes from the control were not shown in any fraction. It has been well known that hemolysis is enhanced by using younger, reticulocyte-rich cell popblations." These can be obtained from the top layer from routine centrifugation of red blood cells or differential centrifugation. The present results support this phenomenon, because the top layer, such as fraction 1, contains more CD59-and DAF-negative erythrocytes. The exact relationship between the amount of CD59 and DAF and the extent of complement hemolysis in vivo and in vitro should be elucidated. 
